Our capabilities in peptide research will establish us as a high-quality player in niche segment. Our agility enables our customers be the first-to-market by providing high quality peptides. The pipeline comprises of oncological, Endocrinological and Gastroenterological etc.
The Therapeutic Peptides includes like Leuprolide, Octreotide, Degarelix, Cetrorelix, Linaclotide, Goserelin, Semaglutide, + 20 more molecules.
Established in 2011, as a private limited company registered under Companies Act, 1956, we are quickly growing towards creating a vast impact on the healthcare industry.